Stanford University
-

Stanford Study Points to Potential Survival Benefit for Diabetes Patients Taking Metformin
A Stanford study reveals type 2 diabetes patients taking metformin before COVID-19 had a 39% lower one-year mortality risk, signaling broader health benefits.

